the info from otc is wrong on many fronts but that shouldn't surprise anyone
1. The FDA doesn't need proof of how you are going to pay for the clinical trials. There is no way to know just exactly how much it will cost. The FDA is only concerned with financial disclosure from the investigators to make sure that if there is any financial conflict of interest, it is out in the open. If you don't know what that is, look it up.
2. Koo's failed business model is built upon the failed idea that he can sell anything he can get past P1 trials for safety. Again, P1 trials do not show any form efficacy. All it shows that the drug or therapy shows no significant side effects and is well tolerated in healthy test subjects.
3. we have heard promises of deals and buyouts for well over a year. So where are they? Not one of the wild predictions have ever come true because not one big pharma or legit biotech is interested in what that fake conman of a CEO has.
Heck, his own brother won't even produce for him after he got that sweet heart payment of $117K for doing not much of anything.
It's a nice gig if you can get it.
News 
Market Data 
Discover 
